surfaceoncology – June is #CancerImmunotherapyMonth, a moment to recognize the great potential of immuno-oncology to help change the lives of patients.
Immuno-oncology can have several medicinal functions, including teaching the immune system to target harmful, cancerous cells and working to enhance innate and adaptive immune responses to stimulate better immune system activation.
At Surface, we’re utilizing this science to develop multiple antibody immunotherapy candidates to enable a robust immunologic response and enhance outcomes for cancer patients.